Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN93,4293,48-1,03
Msft-0,06
Nokia5,7285,80,40
IBM0,17
Mercedes-Benz Group AG59,2859,31-0,24
PFE0,24
27.12.2025 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 23.12.2025 10:58:31
PAUL HARTMANN (PHHGn.F, Frankfurt)
Závěr k 23.12.2025 Změna (%) Změna (EUR) Objem obchodů (EUR)
224,00 -2,18 -5,00 2 464
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti

Business Summary: Paul Hartmann AG is a Germany-based holding company that is principally engaged in the field of medical and healthcare products. The Company operates through four segments, namely Wound Management, Incontinence Management, Infection Management and Other Group Activities. The Wound Management segment comprises wound dressings, as well as products for compression treatment, immobilization, First Aid and diagnostic devices. The Incontinence Management segment includes absorbent products worn close to the body for incontinence hygiene, such as under pads for patients as well as patient hygiene products and medical skin care. The Infection Management segment covers a range of custom procedure trays, surgical draping systems, surgical clothing, and surgical and examination gloves as well as the disinfection assortment. The Other Group Activities includes activities in cotton-wool products, feminine hygiene, baby care, medical consumer goods and pharmaceutical products, among others.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Paul Hartmann AG revenues increased 2% to EUR1.21B. Net income decreased 63% to EUR15.9M. Revenues reflect Wound Management segment increase of 3% to EUR309.9M, Infection Management segment increase of 2% to EUR266.9M, Germany segment increase of 4% to EUR377.3M, Americas segment increase of 16% to EUR45.2M. Net income was offset by Other Operating Expenses increase of 13% to EUR323.7M (expense).



  • Poslední aktualizace:
Management společnosti
Data nejsou k dispozici